Athyrium Capital Management
Overview
Athyrium Capital Management is a specialized asset management firm that focuses on investment opportunities in the global healthcare and life sciences sectors, including pharmaceuticals, medical devices, and healthcare services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Clover Health | Dec 2015 | Series B | Lead |
| RVL Pharmaceuticals | Aug 2023 | Private Placement | Co-investor |
| OrangeTwist | Dec 2025 | Strategic | Co-investor |
| Longevity Health Plan | Mar 2019 | Seed | Co-investor |
| Oui Therapeutics | Aug 2022 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Jeffrey Ferrell
Managing Partner
Courtney Paul
Associate General Counsel Vice President, Investor Relations
April Pun
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Athyrium Capital Management based?
Athyrium Capital Management is headquartered in New York City, New York, United States.
When was Athyrium Capital Management founded?
Athyrium Capital Management was founded in 2008.
How many portfolio companies does Athyrium Capital Management have?
Athyrium Capital Management has 33 portfolio companies in Caplight's dataset.
What are some companies in Athyrium Capital Management's portfolio?
Portfolio companies visible on Caplight include Clover Health, RVL Pharmaceuticals, OrangeTwist, Longevity Health Plan, Oui Therapeutics.
What was Athyrium Capital Management's most recent investment shown here?
Athyrium Capital Management's most recent investment in this portfolio sample was in OrangeTwist in 2025.
What sectors does Athyrium Capital Management focus on?
Athyrium Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, Consumer & Commerce, Mobility, Transportation & Logistics, Enterprise Software.
What company stages does Athyrium Capital Management focus on?
Athyrium Capital Management typically invests at the MultiStage stage.
What is Athyrium Capital Management's AUM?
Athyrium Capital Management's assets under management are estimated between $1.0B and $10.0B.